[go: up one dir, main page]

DK1222180T3 - Enantiomere forbindelser til behandling af hjertearytmier og fremgangsmåde til anvendelse - Google Patents

Enantiomere forbindelser til behandling af hjertearytmier og fremgangsmåde til anvendelse

Info

Publication number
DK1222180T3
DK1222180T3 DK00972216T DK00972216T DK1222180T3 DK 1222180 T3 DK1222180 T3 DK 1222180T3 DK 00972216 T DK00972216 T DK 00972216T DK 00972216 T DK00972216 T DK 00972216T DK 1222180 T3 DK1222180 T3 DK 1222180T3
Authority
DK
Denmark
Prior art keywords
compounds
treatment
cardiac arrhythmias
methods
enantiomeric compounds
Prior art date
Application number
DK00972216T
Other languages
Danish (da)
English (en)
Inventor
Pascal Druzgala
Peter G Milner
Original Assignee
Aryx Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/680,873 external-priority patent/US6372783B1/en
Application filed by Aryx Therapeutics filed Critical Aryx Therapeutics
Application granted granted Critical
Publication of DK1222180T3 publication Critical patent/DK1222180T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00972216T 1999-10-15 2000-10-13 Enantiomere forbindelser til behandling af hjertearytmier og fremgangsmåde til anvendelse DK1222180T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15960999P 1999-10-15 1999-10-15
US09/680,873 US6372783B1 (en) 1999-10-15 2000-10-06 Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
US09/684,046 US6362223B1 (en) 1999-10-15 2000-10-06 Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
PCT/US2000/028636 WO2001029018A2 (fr) 1999-10-15 2000-10-13 Nouveaux composes enantiomeres pour le traitement des arythmies cardiaques et procedes d'utilisation

Publications (1)

Publication Number Publication Date
DK1222180T3 true DK1222180T3 (da) 2007-12-27

Family

ID=27388333

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00972216T DK1222180T3 (da) 1999-10-15 2000-10-13 Enantiomere forbindelser til behandling af hjertearytmier og fremgangsmåde til anvendelse

Country Status (11)

Country Link
EP (1) EP1222180B1 (fr)
JP (1) JP4684514B2 (fr)
AT (1) ATE369351T1 (fr)
AU (1) AU774873B2 (fr)
CA (1) CA2392016C (fr)
DE (1) DE60035888T2 (fr)
DK (1) DK1222180T3 (fr)
ES (1) ES2290054T3 (fr)
HK (1) HK1049829B (fr)
PT (1) PT1222180E (fr)
WO (1) WO2001029018A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038557A2 (fr) * 1993-06-16 2002-05-16 Aryx Therapeutics Nouveaux composes destines au traitement d'arythmie cardiaque, synthese et procedes d'utilisation
JP2004513167A (ja) * 2000-10-06 2004-04-30 アリックス　セラピューティクス 心不整脈を治療するためのベンゾイルベンゾフラン誘導体
DE10129119B4 (de) * 2001-06-16 2007-10-04 Schwarz Pharma Ag Kristalline Salze von Benzoylbenzofuran-Derivaten, insbesondere von[2-(4-{1-[2-((S)-sec.-Butoxycarbonylmethyl)-benzofuran-3-carbonyl]-methanoyl}-2,6-diiod-phenoxy)-ethyl]-diethylamino und [2-(4-{1-[(3-Methyl-2-(S)-Butoxycarbonylmethyl)-benzofuran-3-carbonyl]- methanoyl}-2,6-diiodphenoxy)-ethyl]-diethylamino, deren Verwendung und Herstellung sowie diese Salze enthaltende Arzneimittel
US7105568B2 (en) * 2004-04-09 2006-09-12 Aryx Therapeutics, Inc. Compounds for treatment of cardiac arrhythmia and methods of use
ES2334712T3 (es) 2005-07-15 2010-03-15 Aryx Therapeutics, Inc. Compuestos precursores antiritmicos, procedimientos de sintesis y uso de los mismos.
WO2010059119A1 (fr) * 2008-11-21 2010-05-27 Astrazeneca Ab Combinaison de tert-butyl(2-{7-[2-(4-cyano-2-fluorophénoxy)éthyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}éthyl)carbamate et de certains benzofuranes antiarythmiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364880A (en) * 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use

Also Published As

Publication number Publication date
CA2392016C (fr) 2010-04-13
ATE369351T1 (de) 2007-08-15
JP4684514B2 (ja) 2011-05-18
AU774873B2 (en) 2004-07-08
EP1222180A2 (fr) 2002-07-17
EP1222180B1 (fr) 2007-08-08
HK1049829A1 (en) 2003-05-30
HK1049829B (en) 2008-02-22
JP2003512364A (ja) 2003-04-02
DE60035888T2 (de) 2007-12-06
PT1222180E (pt) 2007-09-20
AU1091201A (en) 2001-04-30
CA2392016A1 (fr) 2001-04-26
ES2290054T3 (es) 2008-02-16
DE60035888D1 (de) 2007-09-20
WO2001029018A2 (fr) 2001-04-26
WO2001029018A3 (fr) 2001-11-29

Similar Documents

Publication Publication Date Title
CY1107763T1 (el) Εναντιομερεις ενωσεις για την αγωγη καρδιακων αρρυθμιων και μεθοδοι χρησεως
AR031828A2 (es) Procedimientos para la preparacion de compuestos espiro-azabiciclicos utiles en terapia
CA2257448A1 (fr) Amides pyridyl-alcene et pyridyl-alcyne acides utilises comme cytostatiques et immunosuppresseurs
AP1635A (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease.
ZA975439B (en) New pyridyl alkane acid amides.
DK1140945T3 (da) Kondenserede 1,2,4-thiadiazinderivater, deres fremstilling og anvendelse
HK1038744A1 (zh) 用於治療炎性疾病的化合物
IL157179A0 (en) Fused heterocyclic compounds
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
MY138145A (en) Thienopyrimidinediones and their use in the modulation of autoimmune disease
GEP19981301B (en) Compounds Containing a Fused Bicyclic Ring, Method of its Preparation and Pharmaceutical Composition
YU24402A (sh) 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja
CA2341031A1 (fr) Forme de sel de pantoprazole
WO2002100858A8 (fr) Composes aromatiques hetero-bicycliques substitues par quinuclidine dans le traitement de maladies
EP1126836A4 (fr) Inhibiteurs benzamidiques de canaux potassiques
NO20013941L (no) Polynukleotider med forkortet kjede og fremgangsmåte ved fremstillingen derav
NO971789L (no) Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler
DK1222180T3 (da) Enantiomere forbindelser til behandling af hjertearytmier og fremgangsmåde til anvendelse
WO1998021213A3 (fr) Derives de 2r,4s,r,s et 2s,4r,r,s-hydroxyitraconazole et hydroxysaperconazole
IL166103A0 (en) Pyrrolidine derivatives and their use
CA2431515A1 (fr) Composition comprenant des diphosphonates pour la prevention et/ou le traitement de maladies metaboliques des os, procede de preparation d'une telle composition et son utilisation
DK0938584T3 (da) Fremgangsmåde til fremstilling af (S)-eller (R)-3,3,3-trifluor-2-hydroxy-2-methylpropionsyre
WO1998056759A3 (fr) Nouveaux derives de pentaerythrite, leur production, leur utilisation et intermediaires pour leur synthese
EP1325918A4 (fr) Inhibiteurs de l'apoptose des cellules du muscle cardiaque et agents therapeutiques/prophylactiques contre les maladies cardiaques
DE60009069D1 (de) Bispidin-derivate zur behandlung von herzarrhythmien